Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

NanoViricides

1.33
+0.02001.53%
Post-market: 1.340.0093+0.70%19:30 EDT
Volume:250.26K
Turnover:338.13K
Market Cap:33.91M
PE:-3.05
High:1.39
Open:1.33
Low:1.31
Close:1.31
52wk High:2.23
52wk Low:0.8500
Shares:25.50M
Float Shares:24.90M
Volume Ratio:0.93
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4355
EPS(LYR):-0.6263
ROE:-89.97%
ROA:-50.46%
PB:3.70
PE(LYR):-2.12

Loading ...

OverviewCompanyNewsFilings

NanoViricides says hantavirus incident highlights need for antiviral drugs

TIPRANKS
·
May 11

NanoViricides says FDA grants orphan drug designation to NV-387 for measles treatment

Reuters
·
May 04

NanoViricides measles virus treatment granted FDA orphan status

TIPRANKS
·
Apr 29

NanoViricides says NV-387 can help control spread of measles

TIPRANKS
·
Apr 21

NanoViricides applies for FDA orphan, rare pediatric designations for measles drug NV-387

Reuters
·
Apr 21

NanoViricides files FDA rare pediatric disease drug designation application for measles drug NV-387

Reuters
·
Apr 08

NanoViricides files application for RPDD for NV-387 with U.S. OPDD

TIPRANKS
·
Apr 07

NanoViricides plans to commence Phase II trial of NV-387 for Monkeypox

TIPRANKS
·
Apr 01

NanoViricides to start Phase II NV-387 mpox trial in Democratic Republic of Congo soon

Reuters
·
Apr 01

NanoViricides completes manufacture of NV-387 oral gummies

TIPRANKS
·
Mar 11

NanoViricides to present at NIBA’s 152nd Investment Conference

Reuters
·
Mar 11

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Sep 29, 2025 Post-Mkt
Financial Report Announcement
May 15, 2025 Post-Mkt
Financial Report Announcement
Feb 14, 2025 Post-Mkt
Financial Report Announcement
Nov 14, 2024 Post-Mkt
Financial Report Announcement
Sep 27, 2024 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-3.05
Current
-2.73
Sector Average
14.85%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-3.05
Maximum
-1.35
+1 STD
-1.59
Minimum
-6.78
-1 STD
-3.86
Average
-2.73

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.